Author:
Shin Kwang-Hee,Chung Yong-ju,Kim Bo-Hyung,Kim Tae-Eun,Kim Hwa-Sook,Cho Joo-Youn,Jang In-Jin,Shin Sang-Goo,Yu Kyung-Sang
Subject
Pharmacology (medical),Pharmacology
Reference14 articles.
1. Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects;Kim;Br J Clin Pharmacol,2008
2. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction;Paick;J Sex Med,2008
3. DA-8159-phase I studies to investigate the safety and pharmacokinetics in healthy male Caucasian subjects;Amakye;Clin Pharmacol Ther,2004
4. Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic;Ji;Xenobiotica,2004
5. Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography;Shim;J Pharm Biomed Anal,2002
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献